Transcriptome sequencing of archived lymphoma specimens is feasible and clinically relevant using exome capture technology-Reference-Cited by-同舟云学术

Transcriptome sequencing of archived lymphoma specimens is feasible and clinically relevant using exome capture technology

Published:2021-10-23 Issue:1 Volume:61 Page:27-36
ISSN:1045-2257
Container-title:Genes, Chromosomes and Cancer
language:en
Short-container-title:Genes Chromosomes Cancer

Author:

Skaftason Aron¹,Qu Ying¹,Abdulla Maysaa²,Nordlund Jessica³,Berglund Mattias⁴,Ednersson Susanne Bram⁵⁶,Andersson Per‐Ola⁷⁸,Enblad Gunilla⁴,Amini Rose‐Marie²,Rosenquist Richard¹⁹,Mansouri Larry¹

Affiliation:

1. Department of Molecular Medicine and Surgery Karolinska Institutet Stockholm Sweden

2. Clinical and Experimental Pathology, Department of Immunology, Genetics and Pathology Uppsala University Uppsala Sweden

3. Department of Medical Sciences and Science for Life Laboratory Uppsala University Uppsala Sweden

4. Experimental and Clinical Oncology, Department of Immunology, Genetics and Pathology Uppsala University Uppsala Sweden

5. Department of Pathology Sahlgrenska University Hospital Gothenburg Sweden

6. Institute of Biomedicine Sahlgrenska Academy at the University of Gothenburg Gothenburg Sweden

7. Department of Medicine, Section of Hematology South Älvsborg Hospital Borås Sweden

8. Institute of Medicine Sahlgrenska Academy at the University of Gothenburg Gothenburg Sweden

9. Clinical Genetics, Karolinska University Laboratory Karolinska University Hospital Stockholm Sweden

Funder

Cancerfonden

Knut och Alice Wallenbergs Stiftelse

Radiumhemmets Forskningsfonder

Vetenskapsrådet

Uppsala Universitet

Science for Life Laboratory

Publisher

Wiley

Subject

Cancer Research,Genetics

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/gcc.23002

Reference38 articles.

1. Tissue issues

2. The use of exome capture RNA-seq for highly degraded RNA with application to clinical cancer sequencing

3. A comprehensive assessment of RNA-seq protocols for degraded and low-quantity samples

4. Molecular subtypes of diffuse large B cell lymphoma are associated with distinct pathogenic mechanisms and outcomes

5. The Use of Molecular Profiling to Predict Survival after Chemotherapy for Diffuse Large-B-Cell Lymphoma

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effects of overwintering on the transcriptome and fitness traits in a damselfly with variable voltinism across two latitudes;Scientific Reports;2024-05-28

2. High‐throughput molecular assays for inclusion in personalised oncology trials – State‐of‐the‐art and beyond;Journal of Internal Medicine;2024-05-02

3. Prognostic impact of miR-125b and miR-155b and their relationship with <i>MYC</i> and <i>TP53</i> in diffuse large B-cell lymphoma: cell-of-origin classification matters;Journal of Clinical and Experimental Hematopathology;2023

4. Genomic profiling for clinical decision making in lymphoid neoplasms;Blood;2022-11-24